Abstract
Opisthotonus is a relatively rare, but challenging neurological symptom of spasticity or dystonia that most often results from a dramatic event such as near-drowning. The classic treatment option for opisthotonus is the oral administration of medication such as benzodiazepines and baclofen. However, results with these medications are usually not very beneficial. Numerous studies however have shown that intrathecal treatment with baclofen (ITB) is an efficient and safe treatment for generalized therapy-resistant spasticity, even in children. In this retrospective study, we describe 11 children (mean age 9 years) with pronounced opisthotonus and quadriplegia caused by different types of acquired lesions who were treated with intrathecal baclofen. Results show that in addition to an expected decrease in muscle tonus, there was also a clear improvement in patient comfort and nursing. A remarkable weight gain was observed in most patients, even when calorie intake did not change. This increase in weight might be due to a reduction in energy expenditure as a result of the decrease in spasticity. Intrathecal treatment with baclofen should be considered in every child with opisthotonus.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albright AL, Ferson SS (2006) Intrathecal baclofen therapy in children. Neurosurg Focus 21(2):e3
Azouvi P, Mane M, Thiebaut JB (1996) Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and long-term follow-up. Arch Phys Med Rehabil 77:35–39
Bottanelli M, Rubini G, Venturelli V, Cosentino A, Rossato G, Vicentini S et al (2004) Weight and height gain after intrathecal baclofen pump implantation in children with spastic tetraparesis. Dev Med Child Neurol 46:788–789
Campbell WM, Ferrel A, McLaughlin JF, Grant GA, Loser JD, Graubert C et al (2002) Long-term safety and efficacy of continuous intrathecal baclofen. Dev Med Child Neurol 44:660–665
Diesing TS (2006) Arc de cercle and dysautonomia from anoxic injury. Mov Disord 21(6):868–869
Francisco GE, Boake C (2003) Improvement in walking speed in poststroke spastic hemiplegia after intrathecal baclofen therapy: a preliminary study. Arch Phys Med Rehabil 84(8):1194–1199
Gerszten PC, Albright AL, Johnstone GF (1998) Intrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsy. J Neurosurg 88:1009–1013
Hemingway C, McGrogan J, Freeman JM (2001) Energy requirements of spasticity. Dev Med Child Neurol 43:277–278
Kenis S, van Rhijn J, Van Havenberg T, Laridon A, Ceulemans B (2006) Intrathecal baclofen (ITB) therapy for spastic children: 7 years of experience. Neuropediatrics 37(suppl. 1):s17 (Abstract)
McCoy AA, Fox MA, Schaubel DE, Ayyangar RN (2006) Weight gain in children with hypertonia of cerebral origin receiving intrathecal baclofen therapy. Arch Phys Med Rehabil 87(11):1503–1508
Stallings VA, Charney EB, Davies JC, Cronck CE (1993) Nutritional status and growth of children with diplegic or hemiplegic cerebral palsy. Dev Med Child Neurol 35:997–1006
Acknowledgements
From Medtronic Belgium, we thank Ben Isebaert and Kathleen Castelein for their long and fine collaboration and Ruben Cornelis for his logistic assistance and statistic support in making this manuscript. The conclusions of this study are made independently from the company.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ceulemans, B., van Rhijn, J., Kenis, S. et al. Opisthotonus and intrathecal treatment with baclofen (ITB) in children. Eur J Pediatr 167, 641–645 (2008). https://doi.org/10.1007/s00431-007-0563-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-007-0563-3